Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
International Journal of Electronic Healthcare|December 1, 2007
Towards evaluating health information portals: a Tasmanian E-health case studyGail Ridley, Judy YoungThe Journal of Primary Prevention|March 3, 2007
Effect of workplace laughter groups on personal efficacy beliefsHeidi Beckman, Nathan Regier, Judy YoungCurrent Opinion in Pharmacology|September 18, 2007
Electrochemiluminescence to detect surface proteins on live cellsYanmei Lu, Judy Young, Y Gloria MengPlos One|March 20, 2012
In vivo depletion of lymphotoxin-alpha expressing lymphocytes inhibits xenogeneic graft-versus-host-diseaseEugene Y Chiang, Ganesh Kolumam, Krista M McCutcheon, et al.Journal of Immunological Methods|May 27, 2015
A novel immunoassay to measure total serum lymphotoxin-α levels in the presence of an anti-LTα therapeutic antibodyJudy Young, Allen Nguyen, Zhihua Julia Qiu, et al.Cytokine|April 2, 2010
Lymphotoxin-alphabeta heterotrimers are cleaved by metalloproteinases and contribute to synovitis in rheumatoid arthritisJudy Young, Xin Yu, Kristen Wolslegel, et al.Proteomics|January 27, 2011
Resurrection of a clinical antibody: template proteogenomic de novo proteomic sequencing and reverse engineering of an anti-lymphotoxin-α antibodyNatalie E Castellana, Krista McCutcheon, Victoria C Pham, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2013
Onartuzumab (MetMAb): using nonclinical pharmacokinetic and concentration-effect data to support clinical developmentHong Xiang, Brendan C Bender, Arthur E Reyes, et al.Cancer Research|June 4, 2008
MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survivalHongkui Jin, Renhui Yang, Zhong Zheng, et al.Nature Medicine|June 30, 2009
Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune diseaseEugene Y Chiang, Ganesh A Kolumam, Xin Yu, et al.Pageof 2